Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference35 articles.
1. A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration;Krebs;Br. J. Ophthalmol.,2013
2. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis;Jaffe;Am J. Ophthalmol.,2008
3. Macula toxicity after intravitreal amikacin;Seawright;Aust. N. Z. J. Ophthalmol.,1996
4. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide;Fung;Br. J. Ophthalmol.,2006
5. Dexamethasone concentration in vitreous and serum after oral administration;Weijtens;Am. J. Ophthalmol.,1998
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effect of suprachoroidal triamcinolone on intraocular pressure: a systematic review and meta-analysis;Therapeutic Advances in Ophthalmology;2024-01
2. Suprachoroidal administration of triamcinolone acetonide in patients with macular edema after vitrectomy: Technique and results;Aspirantskiy Vestnik Povolzhiya;2023-12-09
3. Recent advances in uveitis therapy: focus on selected phase 2 and 3 clinical trials;Expert Opinion on Emerging Drugs;2023-10-02
4. Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle;International Journal of Pharmaceutics;2023-10
5. Refractory post-surgical cystoid macular edema managed following suprachoroidal microcatheterization and delivery of triamcinolone;BMC Ophthalmology;2023-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3